Numerous clinical trials, spanning Early Phase 1 through Phase 4, investigate kisspeptin-related signaling pathways and associated endocrine and metabolic interventions. These studies evaluate diverse conditions—including metabolic disease, reproductive phenomena, sterility, growth hormone disorders, and advanced solid tumors—and assess the impacts of kisspeptin-10 administration on reproductive axis responsiveness and glucose-stimulated insulin secretion. Conducted by academic institutions, medical centers, and pharmaceutical companies, these trials encompass recruitment statuses including completed, active, recruiting, terminated, and withdrawn.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT07321028 | ENROLLING_BY_INVITATION | Cellular Injury and Post-Cryogenic Recovery; Cryogenic Cellular Stress; Cold-Induced Cellular Injury; Thermal Injury Response; Post-Thaw Viability Impairment; Osmotic Stress Injury; Biomechanical Injury Modeling (In-Vitro); Blunt Force Injuries to the Extremities (Cellular Injury Model); Tissue Damage and Recovery Pathways; Hypothermic Tissue Stress; Cellular Regeneration and Repair |
Truway Health, Inc. |
2025-12-10 | EARLY_PHASE1 |
| NCT00117936 | NOT_YET_RECRUITING | Coronary Disease; Coronary Heart Disease; Myocardial Ischemia; Coronary Arteriosclerosis |
Venturis Therapeutics, Inc. |
2027-09-01 | PHASE2 |
| NCT07593859 | RECRUITING | Healthy Adult Participants |
Northeastern University |
2026-02-01 | |
| NCT07659028 | NOT_YET_RECRUITING | Prediabetes; Obesity & Overweight; Inflamation; Oxidative Stress |
National and Kapodistrian University of Athens |
2026-07-01 | |
| NCT07658352 | NOT_YET_RECRUITING | B-Cell Non-Hodgkin Lymphoma |
Shanghai Helioson Pharmaceutical Co., Ltd. |
2026-06-26 | PHASE1; PHASE2 |
| NCT06914128 | RECRUITING | MTAP-deleted Solid Tumors |
Bayer |
2025-03-21 | PHASE1; PHASE2 |
| NCT07321106 | RECRUITING | Colorectal Cancer; Colorectal Cancer (CRC); Colorectal (Colon or Rectal) Cancer; CRC; Metastatic Colon Cancer; Colon Cancer; Advanced Colorectal Cancer |
Cartography Biosciences |
2026-01-15 | PHASE1 |
| NCT06841913 | RECRUITING | Smoke Exposure; Influenza |
University of North Carolina, Chapel Hill |
2025-09-26 | PHASE4 |
| NCT07775391 | RECRUITING | Premature Ovarian Insufficiency |
Shenzhen Wingor Biotechnology Co., Ltd. |
2026-08-03 | PHASE1; PHASE2 |
| NCT06956209 | RECRUITING | Underactive Bladder |
Iota Biosciences, Inc |
2025-09-24 | |
| NCT07418177 | NOT_YET_RECRUITING | AMD - Age-Related Macular Degeneration |
The First Affiliated Hospital with Nanjing Medical University |
2026-02-10 | PHASE1; PHASE2 |
| NCT05912621 | RECRUITING | Obesity; Overweight and Obesity; Overweight |
Stanford University |
2023-11-09 | PHASE2 |
| NCT07515066 | NOT_YET_RECRUITING | Idiopathic Pulmonary Fibrosis (IPF) |
Huan Ye |
2026-05-01 | PHASE1 |
| NCT07332455 | RECRUITING | Neoplasms, Prostate |
GlaxoSmithKline |
2026-02-10 | PHASE1; PHASE2 |
| NCT07180355 | RECRUITING | Friedreich's Ataxia (FA) |
Solid Biosciences Inc. |
2025-10-22 | PHASE1 |
| NCT07628127 | RECRUITING | Obesity; Overweight |
Verdiva Bio Dev Limited |
2026-07-06 | PHASE1 |
| NCT06053814 | ACTIVE_NOT_RECRUITING | Duchenne Muscular Dystrophy |
NS Pharma, Inc. |
2024-09-18 | PHASE1; PHASE2 |
| NCT07612891 | RECRUITING | Breast Cancer (Locally Advanced or Metastatic); Advanced Solid Cancers; Metastatic (Stage IV) Breast Cancer; Ovarian Cancer; Endometrial Cancer |
Shenzhen Ionova Life Sciences Co., Ltd. |
2025-07-04 | PHASE1; PHASE2 |
| NCT07222865 | WITHDRAWN | Brain Imaging |
Virginia Polytechnic Institute and State University |
2026-01 | |
| NCT05510830 | NOT_YET_RECRUITING | Human Papilloma Virus Infection; Human Papilloma Virus Integration; Cervical Intraepithelial Neoplasia; Cervical Cancer; Cervical Conization |
Tongji Hospital |
2022-10 | |
| NCT07454915 | RECRUITING | Cervical Intraepithelial Neoplasia Grade 2/3; Human Papilloma Virus Infection Type 16 |
PapiVax Biotech, Inc. |
2026-04-01 | PHASE2 |
| NCT06872060 | NOT_YET_RECRUITING | Kidney Diseases |
Bispebjerg Hospital |
2026-06-01 | |
| NCT07649044 | NOT_YET_RECRUITING | Smoking Cessation |
The University of Hong Kong |
2026-06-27 | |
| NCT06544655 | ACTIVE_NOT_RECRUITING | Advanced Solid Tumors |
Bristol-Myers Squibb |
2024-10-10 | PHASE1 |
| NCT06148025 | RECRUITING | Vaccine Response Impaired |
South Australian Health and Medical Research Institute |
2023-11-23 | PHASE4 |
| NCT07555483 | RECRUITING | Alpha 1 Antitrypsin Deficiency |
Grifols Therapeutics LLC |
2026-05-05 | PHASE3 |
| NCT05621668 | ACTIVE_NOT_RECRUITING | Soft Tissue Sarcoma; Bone Sarcoma |
M.D. Anderson Cancer Center |
2023-09-08 | PHASE1 |
| NCT07041801 | RECRUITING | Systemic Lupus Erythematosus (SLE) |
Shenzhen Beike Bio-Technology Co., Ltd. |
2025-06-28 | PHASE1; PHASE2 |
| NCT07164313 | RECRUITING | Hepatocellular Carcinoma; Squamous Cell Non-Small Cell Lung Cancer; Germ Cell Tumor |
Zymeworks BC Inc. |
2025-10-21 | PHASE1 |
| NCT05696561 | RECRUITING | OAG - Open-Angle Glaucoma |
New World Medical, Inc. |
2025-09-09 | |
| NCT05818683 | RECRUITING | Metastatic Castration-resistant Prostate Neoplasms; Metastatic Hormone-sensitive Prostate Cancer |
Janssen Research & Development, LLC |
2023-04-26 | PHASE1 |
| NCT05969041 | RECRUITING | Epithelial Tumors, Malignant |
Myeloid Therapeutics |
2023-08-02 | PHASE1 |
| NCT07060690 | NOT_YET_RECRUITING | Depression Symptoms; Depression - Major Depressive Disorder; Depressive Disorder |
Francesc Colom, PsyD, PhD |
2026-01 | |
| NCT07048405 | RECRUITING | Brown Adipose Tissue; Cold Exposure; 18F-FDG PET/CT |
University of Edinburgh |
2025-05-01 | |
| NCT03821935 | ACTIVE_NOT_RECRUITING | Advanced Solid Tumors Cancer |
AbbVie |
2019-02-21 | PHASE1 |
| NCT05332301 | RECRUITING | Healthy Nutrition |
Kirsten Bell |
2022-10-04 | |
| NCT05270213 | RECRUITING | Advanced Cancer |
Riboscience, LLC. |
2022-07-11 | PHASE1 |
| NCT06667687 | ACTIVE_NOT_RECRUITING | Non-Hodgkin's Lymphoma |
AbbVie |
2025-01-16 | PHASE1 |
| NCT06705322 | NOT_YET_RECRUITING | Human Papillomavirus (HPV) Infection; Cervical Cancer |
Fudan University |
2024-12-01 | PHASE2 |
| NCT05307939 | RECRUITING | HPV; Oropharynx Cancer; HPV-Related Carcinoma; HPV-Related Malignancy; HPV Positive Oropharyngeal Squamous Cell Carcinoma |
Memorial Sloan Kettering Cancer Center |
2022-03-24 | PHASE2 |
| NCT07150416 | NOT_YET_RECRUITING | Multiple Pulmonary Ground-Glass Nodules; Lung Neoplasms; Precancerous Conditions |
The First Affiliated Hospital of Guangzhou Medical University |
2025-10-01 | PHASE2 |
| NCT06667544 | RECRUITING | KRAS G12D Mutation |
Ranok Therapeutics (Hangzhou) Co., Ltd. |
2024-11-08 | PHASE1; PHASE2 |
| NCT06202261 | RECRUITING | Metastatic Breast Cancer; Recurrent Breast Cancer; Advanced Malignancies |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2023-04-13 | PHASE1; PHASE2 |
| NCT04532489 | RECRUITING | Radiotracer; Hypertension; Cholesterol |
Benjamin Viglianti |
2021-01-18 | EARLY_PHASE1 |
| NCT06063850 | RECRUITING | Mesial Temporal Lobe Epilepsy |
UniQure Biopharma B.V. |
2024-06-12 | PHASE1; PHASE2 |
| NCT06635447 | ACTIVE_NOT_RECRUITING | Breast Cancer |
AstraZeneca |
2024-09-26 | PHASE3 |
| NCT07525089 | ENROLLING_BY_INVITATION | VRE Colonization; CRE Colonization |
BioMe Inc. |
2026-03-23 | |
| NCT07557979 | NOT_YET_RECRUITING | Obesity (BMI>30) |
Texas Tech University |
2026-05-15 | |
| NCT07149337 | NOT_YET_RECRUITING | Aging; Kidney Disease; Mineral Metabolism |
University of Zurich |
2025-09-30 | |
| NCT04101188 | RECRUITING | Cardiovascular Risk Factor |
University of Delaware |
2020-01-16 | |
| NCT06137157 | COMPLETED | Netherton Syndrome |
Azitra Inc. |
2024-06-16 | PHASE1 |
| NCT04711915 | ACTIVE_NOT_RECRUITING | Major Depressive Disorder; Depression |
Yale University |
2021-03-17 | PHASE1 |
| NCT06501196 | RECRUITING | Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Preleukemia; Myelodysplastic Syndromes; Refractory Acute Myeloid Leukemia |
BlossomHill Therapeutics |
2024-06-19 | PHASE1 |
| NCT06588257 | COMPLETED | HPV |
Fundación Huésped |
2024-10-09 | PHASE4 |
| NCT07118852 | COMPLETED | Human Milk |
University of Wisconsin, Madison |
2025-11-14 | |
| NCT06877208 | ACTIVE_NOT_RECRUITING | Cerebral Glucose Metabolism |
Nicolai Jacob Wewer Albrechtsen |
2025-03-18 | |
| NCT06939959 | COMPLETED | Dry Eye; Insulin Sensitivity |
Khyber Teaching Hospital |
2025-04-14 | PHASE4 |
| NCT07543627 | ACTIVE_NOT_RECRUITING | Nurse Training; Geriatric; Communication Skills; EMPATHY İN NURSİNG |
Gazi University |
2026-04-15 | |
| NCT05945628 | ACTIVE_NOT_RECRUITING | Memory |
University of Chicago |
2023-01-16 | |
| NCT07691177 | COMPLETED | Type 2 Diabetes |
Humanis Saglık Anonim Sirketi |
2026-02-06 | PHASE1 |
| NCT06799741 | COMPLETED | DENV-3 Controlled Human Infection Model |
AbViro LLC |
2025-01-07 | PHASE2 |
| NCT04803058 | TERMINATED | Kidney Transplantation |
ITB-Med LLC |
2022-12-14 | PHASE2 |
| NCT05698199 | COMPLETED | Glioblastoma |
Immunomic Therapeutics, Inc. |
2023-08-21 | PHASE1 |
| NCT06831929 | RECRUITING | HPV Vaccine |
University of California, Davis |
2025-02-28 | |
| NCT06011772 | ACTIVE_NOT_RECRUITING | Colo-rectal Cancer |
Roswell Park Cancer Institute |
2023-12-18 | EARLY_PHASE1 |
| NCT05600062 | ACTIVE_NOT_RECRUITING | Acute Respiratory Distress Syndrome |
Queen Mary University of London |
2023-03-21 | |
| NCT07784283 | COMPLETED | Human Papillomavirus Vaccination; Cervical Cancer Prevention |
Clinton Health Access Initiative Inc. |
2024-12-01 | |
| NCT06562361 | UNKNOWN | MASH; PSC; Fibrostenotic Crohn's Disease; Healthy Volunteers |
Antaros Medical |
2024-08 | EARLY_PHASE1 |
| NCT06731374 | RECRUITING | Pneumococcal Disease; Pneumococcal Carriage |
University of Oxford |
2025-02-24 | PHASE4 |
| NCT06126354 | WITHDRAWN | Insulin Resistance; Prediabetic State; Non-Alcoholic Fatty Liver Disease; Overweight and Obesity |
Columbia University |
2024-07-01 | PHASE1 |
| NCT07319221 | COMPLETED | Detecting Number of Root Canal of Human Mandibular Second Molar |
Future University in Egypt |
2024-11-29 | |
| NCT05424822 | ACTIVE_NOT_RECRUITING | Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell |
Janssen Research & Development, LLC |
2022-08-18 | PHASE1 |
| NCT06589128 | RECRUITING | Digital Eye Strain (DES) |
Universiti Sains Malaysia |
2024-10-01 | |
| NCT05203835 | COMPLETED | Lymphedema of Upper Arm |
Stanford University |
2022-07-27 | PHASE2 |
| NCT05634174 | ACTIVE_NOT_RECRUITING | Obesity, Prediabetes |
University of California, San Diego |
2023-08-01 | PHASE1 |
| NCT06156488 | COMPLETED | Sinus Floor Augmentation |
Universidad de Granada |
2023-09-04 | |
| NCT05997095 | ACTIVE_NOT_RECRUITING | Skeletal Muscle Atrophy |
University of Nottingham |
2023-05-22 | |
| NCT07344688 | COMPLETED | Healhty |
Universitas Padjadjaran |
2025-08-22 | |
| NCT06331559 | TERMINATED | Advanced Solid Tumors |
Jiangsu Simcere Pharmaceutical Co., Ltd. |
2024-03-19 | PHASE1 |
| NCT04710043 | COMPLETED | Solid Tumor |
BioNTech SE |
2021-06-08 | PHASE1 |
| NCT06866379 | RECRUITING | Alcohol Use Disorder |
Anders Fink-Jensen, MD, DMSci |
2025-05-07 | |
| NCT06082440 | UNKNOWN | Osteoarthritis, Knee |
First Affiliated Hospital of Wannan Medical College |
2023-11-22 | EARLY_PHASE1 |
| NCT06074705 | TERMINATED | Advanced Solid Tumor |
Daiichi Sankyo Co., Ltd. |
2023-08-04 | PHASE1 |
| NCT06650644 | COMPLETED | Autism Spectrum Disorder |
Miae Oh |
2024-10-10 | |
| NCT06525272 | UNKNOWN | Pleurisy |
Healthgen Biotechnology Corp. |
2024-07 | PHASE1 |
| NCT06724900 | ACTIVE_NOT_RECRUITING | Wrinkles in Decolletage; Pigmentation; Décolleté Wrinkles |
Krystal Biotech, Inc. |
2024-11-20 | PHASE1; PHASE2 |
| NCT05983627 | NOT_YET_RECRUITING | Acute Respiratory Distress Syndrome |
Asia Cell Therapeutics (Shanghai) Co., Ltd. |
2023-08-30 | PHASE1 |
| NCT07045636 | COMPLETED | Microbial Colonization; Peri-Implantitis |
Jamil awad shibli |
2025-05-11 | |
| NCT04193709 | COMPLETED | Urinary Bladder, Neurogenic; Blood Pressure; Autonomic Dysreflexia; Bowel Incontinence |
University of Louisville |
2021-01-04 | |
| NCT05232851 | ACTIVE_NOT_RECRUITING | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Human Papillomavirus-Related Carcinoma; Locally Advanced Oropharyngeal Carcinoma; Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8; Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8 |
Mayo Clinic |
2022-06-16 | PHASE1; PHASE2 |
| NCT06435936 | ACTIVE_NOT_RECRUITING | PHA1A |
SAb Biotherapeutics, Inc. |
2024-04-22 | PHASE1 |
| NCT06345755 | COMPLETED | Autosomal Dominant Polycystic Kidney Disease (ADPKD) |
Vertex Pharmaceuticals Incorporated |
2024-04-17 | PHASE1 |
| NCT04994912 | COMPLETED | Healthy |
Elixiron Immunotherapeutics (Hong Kong) Ltd. |
2021-10-01 | PHASE1 |
| NCT05555446 | SUSPENDED | Celiac Disease; Gluten Sensitivity; Non-celiac Gluten Sensitivity |
Milky Way Life Sciences LLC |
2022-09-22 | EARLY_PHASE1 |
| NCT06404905 | RECRUITING | Advanced Solid Tumor |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2024-01-24 | PHASE1 |
| NCT05275855 | COMPLETED | Healthy Volunteers |
Novartis Pharmaceuticals |
2022-04-29 | PHASE1 |
| NCT06467201 | COMPLETED | Healthy Postmenopausal Women |
Amneal Pharmaceuticals, LLC |
2024-06-03 | PHASE1 |
| NCT05511415 | COMPLETED | Postpartum Hemorrhage |
Samuel Lunenfeld Research Institute, Mount Sinai Hospital |
2022-11-02 | |
| NCT03369223 | COMPLETED | Advanced Cancer |
Bristol-Myers Squibb |
2017-12-06 | PHASE1; PHASE2 |
| NCT06080048 | COMPLETED | Ulcerative Colitis |
Sorriso Pharmaceuticals, Inc. |
2023-10-24 | PHASE1 |
| NCT05291975 | COMPLETED | Neuropathy, Diabetic; Neuropathy;Peripheral; Neuropathy, Painful |
Erchonia Corporation |
2022-02-17 | |
| NCT05267899 | UNKNOWN | Advanced Solid Tumors |
Zhejiang Haichang Biotech Co., Ltd. |
2022-08-01 | PHASE1 |
| NCT04532801 | WITHDRAWN | Insulin; Glucose; Healthy Volunteers; Women; Pregnancy |
Stephanie B. Seminara, MD |
2019-09-01 | PHASE1 |
| NCT05436223 | UNKNOWN | B-cell Non-Hodgkin's Lymphoma |
Hrain Biotechnology Co., Ltd. |
2021-08-09 | PHASE2 |
| NCT05456854 | WITHDRAWN | Metabolic Disease |
Massachusetts General Hospital |
2022-06-03 | PHASE1 |
| NCT06212804 | COMPLETED | Healthy Volunteers |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2023-11-21 | PHASE1 |
| NCT05933525 | COMPLETED | Diarrhea; Travelers Diarrhea; Infectious Diarrhea |
Immuron Ltd. |
2023-05-29 | PHASE2 |
| NCT06090370 | COMPLETED | Silicosis |
Johns Hopkins University |
2024-01-24 | |
| NCT06909370 | COMPLETED | Human Papilloma Virus (HPV) |
Saglik Bilimleri Universitesi |
2024-05-01 | |
| NCT05613036 | COMPLETED | Solid Tumors |
Boehringer Ingelheim |
2023-01-03 | PHASE1 |
| NCT05907395 | COMPLETED | Healthy Participants |
Pfizer |
2023-08-09 | PHASE1 |
| NCT04763759 | COMPLETED | Prosthetic Joint Infection |
Trellis Bioscience LLC |
2021-02-08 | PHASE1 |
| NCT03950778 | COMPLETED | Albumin Supplementation; Albumin Therapy; Sepsis |
University of Pecs |
2023-03-04 | EARLY_PHASE1 |
| NCT05686733 | COMPLETED | Aneurysms Saccular; Aneurysm, Ruptured; Aneurysm |
Galaxy Therapeutics INC |
2022-01-26 | |
| NCT05901883 | COMPLETED | Healthy |
Celsius Therapeutics, Inc. |
2023-06-20 | PHASE1 |
| NCT05498597 | UNKNOWN | Advanced Solid Tumor; Advanced Cancer; Advanced Carcinoma; Ovarian Cancer; Ovarian Carcinoma; Ovarian Epithelial Cancer; Ovarian Endometrioid Adenocarcinoma; Endometrial Cancer; Endometrial Adenocarcinoma; Endometrial Serous Adenocarcinoma; Endometrial Endometrioid Adenocarcinoma; Endometrial Clear Cell Adenocarcinoma; Lung Adenocarcinoma; Triple Negative Breast Cancer; Pancreatic Ductal Adenocarcinoma; Malignant Pleural Mesothelioma; Ovarian Clear Cell Carcinoma; Ovarian Clear Cell Adenocarcinoma; Ovarian Mucinous Adenocarcinoma |
Multitude Therapeutics Inc. |
2023-01-25 | PHASE1 |
| NCT05755685 | UNKNOWN | Peritoneal Metastases; Colorectal Cancer |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2023-02-10 | PHASE2 |
| NCT04129710 | UNKNOWN | Recurrent/RefractoryPrimary Central Nervous System Lymphoma (PCNSL) |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2020-01-01 | PHASE2 |
| NCT04227496 | UNKNOWN | Healthy; Pain |
University College of Northern Denmark |
2020-01-13 | |
| NCT05954923 | COMPLETED | Healthy |
University Hospital, Gentofte, Copenhagen |
2023-09-05 | |
| NCT03493542 | COMPLETED | Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in Situ |
Merck Sharp & Dohme LLC |
2018-08-31 | PHASE3 |
| NCT05556967 | COMPLETED | Adherence, Patient |
University of Mississippi Medical Center |
2023-08-09 | PHASE3 |
| NCT03163511 | COMPLETED | Type 1 Diabetes Mellitus With Hypoglycemia |
ViaCyte |
2017-07-06 | PHASE1; PHASE2 |
| NCT03739645 | TERMINATED | Fear Pain |
Johns Hopkins University |
2020-08-01 | |
| NCT04963413 | TERMINATED | Glioblastoma |
University of Florida |
2022-01-13 | PHASE1 |
| NCT05883943 | ACTIVE_NOT_RECRUITING | Venous Insufficiency of Leg |
MED Institute Inc. |
2023-04-24 | |
| NCT05676801 | UNKNOWN | Prosthesis and Implants; Surgical Site Infection; Prosthetic Joint Infection; Postoperative Wound Infection Deep Incisional Surgical Site |
University of Zurich |
2023-02-04 | EARLY_PHASE1 |
| NCT05032599 | TERMINATED | T-Cell Acute Lymphoblastic Leukemia |
Beijing Boren Hospital |
2021-09-14 | PHASE1 |
| NCT04053283 | COMPLETED | Metastatic Cancer; Epithelial Tumor |
Akamis Bio |
2020-01-23 | PHASE1 |
| NCT04457778 | COMPLETED | Metastatic Solid Tumors |
EMD Serono Research & Development Institute, Inc. |
2020-07-10 | PHASE1 |
| NCT05090111 | COMPLETED | NASH - Nonalcoholic Steatohepatitis |
Aligos Therapeutics |
2021-12-01 | PHASE1 |
| NCT06281470 | COMPLETED | Hyperkalemia |
Waterstone Pharmaceutical (Wuhan) Co., LTD. |
2023-02-13 | PHASE1 |
| NCT05801653 | COMPLETED | Healthy |
Lund University |
2023-03-08 | |
| NCT05091684 | TERMINATED | Hematological Patients; Bleeding; Platelet Refractoriness |
Centre Hospitalier Universitaire de Saint Etienne |
2022-02-10 | PHASE2 |
| NCT05515614 | COMPLETED | Premature Birth; Breastmilk Collection; Postnatal Growth Restriction |
Loma Linda University |
2022-08-17 | |
| NCT04950101 | COMPLETED | Human Papilloma Virus |
Universitair Ziekenhuis Brussel |
2020-10-20 | |
| NCT04100200 | ACTIVE_NOT_RECRUITING | Overweight or Obesity; Healthy |
Clinical Nutrition Research Center, Illinois Institute of Technology |
2019-10-07 | |
| NCT04338659 | COMPLETED | Advanced Malignant Tumors Lymphomas |
Innovent Biologics (Suzhou) Co. Ltd. |
2021-01-14 | PHASE1 |
| NCT04014166 | COMPLETED | Thrombocytopenia; Mesenchymal Stem Cells |
Institute of Hematology & Blood Diseases Hospital, China |
2019-11-21 | |
| NCT04162639 | WITHDRAWN | Burns |
Virginia Commonwealth University |
2021-02 | PHASE4 |
| NCT04853017 | COMPLETED | Minimal Residual Disease; KRAS G12D; KRAS G12R; NRAS G12D; NRAS G12R; Pancreatic Ductal Adenocarcinoma; Colorectal Cancer; Non-small Cell Lung Cancer; Ovarian Cancer; Cholangiocarcinoma; Bile Duct Cancer; Gallbladder Carcinoma |
Elicio Therapeutics |
2021-10-04 | PHASE1 |
| NCT04880837 | COMPLETED | Human Papillomavirus-Related Carcinoma |
Ohio State University Comprehensive Cancer Center |
2022-04-27 | |
| NCT02703493 | COMPLETED | Cancer of the Oropharynx |
Northwell Health |
2010-03-01 | |
| NCT05448417 | UNKNOWN | Non-invasive Ventilation; Healthy Subjects |
Guangzhou Institute of Respiratory Disease |
2022-07-15 | |
| NCT04403763 | TERMINATED | Presbyopia |
AbbVie |
2020-07-27 | PHASE1; PHASE2 |
| NCT04561882 | UNKNOWN | Atrial Septal Aneurysm |
China National Center for Cardiovascular Diseases |
2020-09-04 | |
| NCT04920825 | COMPLETED | Endocrine and Metabolic Secondary Hypertension |
Universiti Sains Malaysia |
2021-05-01 | |
| NCT02341807 | COMPLETED | Choroideremia; CHM (Choroideremia) Gene Mutations |
Spark Therapeutics, Inc. |
2015-01-15 | PHASE1; PHASE2 |
| NCT05033444 | COMPLETED | Traumatic Brain Injury (TBI) |
Odyssey Group International, Inc. |
2022-02-09 | PHASE1 |
| NCT05252338 | COMPLETED | Influenza |
CureVac |
2022-02-07 | PHASE1 |
| NCT04753580 | COMPLETED | Healthy Volunteers; Frail Volunteers |
University Hospital, Clermont-Ferrand |
2021-10-04 | |
| NCT01659307 | COMPLETED | Acute Lung Injury |
Belfast Health and Social Care Trust |
2012-09 | PHASE2 |
| NCT03724747 | COMPLETED | Metastatic Castration Resistant Prostate Cancer (mCRPC) |
Bayer |
2018-12-18 | PHASE1 |
| NCT06411743 | COMPLETED | Hepatic Ascites |
The First Hospital of Jilin University |
2021-09-07 | PHASE2 |
| NCT04696146 | COMPLETED | End Stage Renal Disease; Chronic Kidney Diseases |
Cedars-Sinai Medical Center |
2021-03-03 | PHASE1; PHASE2 |
| NCT03457701 | COMPLETED | Anaemia |
GlaxoSmithKline |
2019-07-30 | PHASE2 |
| NCT05372016 | COMPLETED | HPV Infections; Cervical Cancer; Vulvar Cancer; Vaginal Cancer; CIN1; CIN2; CIN3; VaIN1; VaIN2; VaIN3; Genital Wart; VIN 1; VIN 2; VIN 3; AIS |
Shanghai Bovax Biotechnology Co., Ltd. |
2020-09-19 | PHASE3 |
| NCT06517485 | COMPLETED | Platinum Resistant Ovarian Cancer; Non-Small Cell Adenocarcinoma |
Mersana Therapeutics |
2019-07-30 | PHASE1 |
| NCT04782895 | COMPLETED | Cervical Cancer; Condylomata Acuminata |
Xiamen University |
2021-03-14 | PHASE3 |
| NCT03788772 | COMPLETED | Sepsis; Acute Circulatory Failure |
Assistance Publique - Hôpitaux de Paris |
2019-07-15 | |
| NCT05506540 | COMPLETED | Healthy |
EnnovaBio |
2021-02-17 | PHASE1 |
| NCT05249374 | COMPLETED | Hepatic Ascites |
Beijing Protgen Biotechnology Development Co., Ltd. |
2021-10-14 | PHASE1 |
| NCT03972722 | UNKNOWN | Cervical Cancer |
Guangzhou Gloria Biosciences Co., Ltd. |
2019-05-15 | PHASE2 |
| NCT05490017 | COMPLETED | Paroxysmal Nocturnal Hemoglobinuria |
Kira Pharmacenticals (US), LLC. |
2020-12-30 | PHASE1 |
| NCT05308615 | COMPLETED | COVID-19 |
Indonesia University |
2021-03-03 | |
| NCT04414592 | UNKNOWN | Lumbar Disc Degeneration; Lumbar Disc Herniation |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2020-08 | |
| NCT04501744 | COMPLETED | Malignant Ascites; Cancer |
Wuhan YZY Biopharma Co., Ltd. |
2018-09-30 | PHASE1 |
| NCT06920589 | COMPLETED | Human Papilloma Virus (HPV) |
Hospital Univeristario Benemerita Universidad Autonoma de Puebla |
2021-12-01 | |
| NCT04644003 | COMPLETED | Autism Spectrum Disorder |
Stalicla SA |
2020-12-07 | PHASE1 |
| NCT04852029 | TERMINATED | Infertility, Female |
Reproductive Medicine Associates of New Jersey |
2021-08-16 | |
| NCT04670302 | UNKNOWN | Supraspinatus Tear |
Dr. Soetomo General Hospital |
2019-10-17 | |
| NCT04551443 | UNKNOWN | Acute Myocardial Infarction |
Navy General Hospital, Beijing |
2020-11-01 | PHASE2 |
| NCT04351672 | COMPLETED | Overweight and Obesity |
German Institute of Human Nutrition |
2020-06-23 | |
| NCT04690426 | COMPLETED | Viral; Infection, Coxsackie(Virus) |
Provention Bio, Inc. |
2020-12-14 | PHASE1 |
| NCT02947191 | UNKNOWN | Chronic Nasal Septum Perforation |
Chinese Academy of Sciences |
2016-11 | PHASE1; PHASE2 |
| NCT03477162 | TERMINATED | Thoracic Neoplasm |
Dartmouth-Hitchcock Medical Center |
2018-05-15 | EARLY_PHASE1 |
| NCT04557098 | ACTIVE_NOT_RECRUITING | Hematological Malignancies |
Janssen Research & Development, LLC |
2020-09-17 | PHASE2 |
| NCT05040113 | COMPLETED | Healthy Adult Subjects |
Connect Biopharm LLC |
2021-09-04 | PHASE1 |
| NCT03720457 | UNKNOWN | CD19-positive; Diffuse Large B-cell Lymphoma; Follicular Lymphoma |
Hrain Biotechnology Co., Ltd. |
2018-11-13 | PHASE1 |
| NCT04123886 | COMPLETED | Malignant Pleural Effusion |
Sichuan Clover Biopharmaceuticals, Inc. |
2020-01-08 | PHASE1 |
| NCT04414631 | TERMINATED | Coronavirus Infections |
University Hospital, Basel, Switzerland |
2020-08-06 | PHASE2 |
| NCT05536934 | COMPLETED | Obese; Endothelial Function |
Karolinska Institutet |
2016-12 | EARLY_PHASE1 |
| NCT03284723 | TERMINATED | Breast Neoplasms |
Pfizer |
2017-11-01 | PHASE1 |
| NCT04375046 | UNKNOWN | COVID-19 |
Kafrelsheikh University |
2021-07 | PHASE1 |
| NCT04501796 | TERMINATED | COVID-19 |
NeoImmuneTech |
2020-11-27 | PHASE1 |
| NCT05166941 | COMPLETED | Psychiatric Nursing |
Ankara Yildirim Beyazıt University |
2021-05-27 | |
| NCT06517433 | COMPLETED | Platinum Resistant Ovarian Cancer; Non Small Cell Lung Cancer Metastatic |
Mersana Therapeutics |
2017-12-12 | PHASE1 |
| NCT03422666 | COMPLETED | Hyperlipidemias |
University Health Network, Toronto |
2018-09-21 | PHASE2; PHASE3 |
| NCT02982772 | COMPLETED | Smoking Cessation; HIV |
dr. maria miguez |
2016-05 | |
| NCT04940910 | UNKNOWN | Immunity |
Chonbuk National University Hospital |
2021-02-22 | |
| NCT04898881 | COMPLETED | Pain |
Wayne State University |
2020-01-01 | PHASE4 |
| NCT06812351 | COMPLETED | Randomized Clinical Trial |
Ain Shams University |
2020-03-22 | PHASE1 |
| NCT04326868 | COMPLETED | Helminths Infection; Drug Resistance |
Centre de Recherche Médicale de Lambaréné |
2019-11-11 | PHASE4 |
| NCT02745808 | UNKNOWN | Erectile Dysfunction; Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus |
Chinese Academy of Sciences |
2015-09 | PHASE1 |
| NCT03313830 | COMPLETED | Healthy |
The University of Texas Medical Branch, Galveston |
2017-10-07 | |
| NCT04564144 | UNKNOWN | Emesis |
Mansoura University |
2020-06-01 | PHASE1; PHASE2 |
| NCT03607942 | COMPLETED | Premature Infant |
Société des Produits Nestlé (SPN) |
2018-08-06 | |
| NCT03746938 | UNKNOWN | Heart Failure With Reduced Ejection Fraction |
Viscofan |
2018-11-13 | PHASE1 |
| NCT03409107 | COMPLETED | Anaemia |
GlaxoSmithKline |
2018-03-05 | PHASE3 |
| NCT03947320 | UNKNOWN | Hemophilia A |
Sinocelltech Ltd. |
2019-12-20 | PHASE3 |
| NCT03829709 | COMPLETED | HTLV-I Infections |
Universidade Metodista de Piracicaba |
2019-01-30 | |
| NCT02824718 | COMPLETED | Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment |
Assistance Publique - Hôpitaux de Paris |
2017-06-06 | PHASE2 |
| NCT03970109 | TERMINATED | Alcohol Use Disorder |
National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
2019-10-08 | PHASE2 |
| NCT04055246 | COMPLETED | Prebiotics and Human Behavior and Cognition |
Duke University |
2019-06-04 | |
| NCT04097938 | COMPLETED | Healthy |
Lakefront Biotherapeutics NV |
2019-09-18 | PHASE1 |
| NCT05246748 | COMPLETED | Breastfeeding Education |
Gamze Durmazoğlu |
2019-01-01 | |
| NCT04011319 | UNKNOWN | Embryo Quality |
Tang-Du Hospital |
2019-04-01 | |
| NCT03780582 | UNKNOWN | Lung Cancer |
Ensemble Group Holdings, LLC |
2018-12-14 | |
| NCT02385123 | TERMINATED | Influenza; Influenza Immunisation |
National Institute of Allergy and Infectious Diseases (NIAID) |
2015-04-01 | PHASE4 |
| NCT03291821 | COMPLETED | Infertility, Female |
IVI Madrid |
2017-12-01 | |
| NCT04007159 | COMPLETED | Skin Care |
GlaxoSmithKline |
2019-08-30 | |
| NCT03658655 | COMPLETED | Type2 Diabetes |
CAR-T (Shanghai) Biotechnology Co., Ltd. |
2018-06-01 | EARLY_PHASE1 |
| NCT03439488 | COMPLETED | Chronic Hepatitis B |
Alios Biopharma Inc. |
2018-03-26 | PHASE1 |
| NCT04075175 | COMPLETED | Diphtheria |
MassBiologics |
2019-04-23 | PHASE1 |
| NCT03796910 | COMPLETED | Healthy Volunteers |
Spero Therapeutics |
2018-12-18 | PHASE1 |
| NCT02232165 | TERMINATED | Acute Spinal Cord Injury |
University of Calgary |
2013-02 | |
| NCT03979690 | COMPLETED | Colonic Polyp; Colon Adenoma; Colorectal Cancer |
Bio-Medical Engineering (HK) Limited |
2019-06-12 | |
| NCT03794180 | COMPLETED | Healthy Adult Subjects |
I-Mab Biopharma US Limited |
2019-03-18 | PHASE1 |
| NCT04071574 | COMPLETED | Female Infertility; Female Infertility Due to Ovulatory Disorder; Premature Ovarian Failure; Polycystic Ovary Syndrome; Female Infertility of Tubal Origin; Ectopic Pregnancy; Salpingitis; Female Infertility Due to Tubal Block; Female Infertility Due to Tubal Occlusion; Hydrosalpinx; Female Infertility - Cervical/Vaginal; Female Infertility Endocrine; Endometriosis; Fibroids; Congenital Uterine Anomaly; Infections Uterine; Female Infertility of Other Origin |
Lebanese University |
2018-02-01 | PHASE1; PHASE2 |
| NCT03707990 | COMPLETED | Obesity and Overweight |
Novo Nordisk A/S |
2018-10-15 | PHASE1 |
| NCT03361605 | COMPLETED | Healthy |
University of Michigan |
2017-04-12 | PHASE4 |
| NCT02372175 | COMPLETED | Dengue |
U.S. Army Medical Research and Development Command |
2015-10 | PHASE1 |
| NCT02857283 | COMPLETED | Environmental Exposure; Nasal Inflammation |
University of North Carolina, Chapel Hill |
2017-04-22 | |
| NCT03801226 | COMPLETED | Potential Applications for Heart Failure; Volume Overload |
Yale University |
2018-12-01 | EARLY_PHASE1 |
| NCT02632266 | COMPLETED | Complication of Prematurity |
University of Kansas Medical Center |
2015-07 | PHASE4 |
| NCT02484092 | COMPLETED | Hemophilia B |
Pfizer |
2015-11-18 | PHASE2 |
| NCT03466073 | COMPLETED | Community-acquired Pneumonia |
BioAegis Therapeutics Inc. |
2018-08-28 | PHASE1; PHASE2 |
| NCT03231033 | COMPLETED | Autoimmune Pulmonary Alveolar Proteinosis |
Children's Hospital Medical Center, Cincinnati |
2017-08-17 | PHASE1 |
| NCT02251041 | COMPLETED | Reperfusion Injury |
Universitaire Ziekenhuizen KU Leuven |
2014-09 | PHASE2 |
| NCT03521258 | UNKNOWN | Wounds; Trauma; Injury; Limb Salvage; Soft Tissue Injuries |
Louisiana State University Health Sciences Center in New Orleans |
2016-02 | |
| NCT03063515 | COMPLETED | Diabetes Mellitus |
University of Miami |
2017-04-19 | PHASE1 |
| NCT02355925 | COMPLETED | Infertility |
Royan Institute |
2014-10 | PHASE3 |
| NCT03651024 | UNKNOWN | Erectile Dysfunction (ED) |
Sano V Pte Ltd |
2018-10 | |
| NCT02429037 | UNKNOWN | Advanced Head and Neck Cancer |
Shenzhen SiBiono GeneTech Co.,Ltd |
2015-05 | PHASE2 |
| NCT02561962 | COMPLETED | Multiple Myeloma |
Amgen |
2015-11-20 | PHASE1 |
| NCT03510091 | COMPLETED | Human Papillomavirus Infection |
Le Bonheur Children's Hospital |
2018-08-30 | |
| NCT03235349 | COMPLETED | Hepatitis C Virus (HCV) |
AbbVie |
2017-09-29 | PHASE3 |
| NCT02237846 | WITHDRAWN | Osteoarthritis of the Knee |
Translational Biosciences |
2014-09 | PHASE1; PHASE2 |
| NCT01578629 | COMPLETED | Ischemic Stroke; Transient Ischemic Attack (TIA) |
Andrew Slivka |
2012-03 | PHASE1; PHASE2 |
| NCT03369327 | COMPLETED | Hepatitis C Virus Infection, Response to Therapy of; Human Immunodeficiency Virus |
Tehran University of Medical Sciences |
2017-01-01 | PHASE3 |
| NCT03530436 | COMPLETED | Safety After Oral Intake; Pharmacokinetics After Oral Intake |
University of Hohenheim |
2018-06-07 | |
| NCT03392441 | COMPLETED | Diabetes Mellitus, Type 1; Diabetes; Diabetes Complications |
Mayo Clinic |
2017-11-30 | |
| NCT02267993 | COMPLETED | Thrombocytopenia |
Institute of Hematology & Blood Diseases Hospital, China |
2014-10 | PHASE4 |
| NCT03806829 | COMPLETED | Endothelial Dysfunction |
University of the Highlands and Islands |
2018-06-06 | |
| NCT02300909 | COMPLETED | Scarring; Spinal Stenosis; Herniated Disc |
MiMedx Group, Inc. |
2014-11 | |
| NCT03032588 | COMPLETED | Healthy |
Janssen Vaccines & Prevention B.V. |
2017-10-09 | PHASE1 |
| NCT02378779 | TERMINATED | Premature Ejaculation |
University Hospital, Brest |
2016-04-22 | |
| NCT03413267 | COMPLETED | Food Structure Impact on Micronutrient Bioavailability |
Françoise Nau |
2017-12-07 | |
| NCT03118349 | TERMINATED | Pancreatic Carcinoma; Tumors That Express CA 19-9 |
BioNTech Research & Development, Inc. |
2017-06-01 | PHASE1 |
| NCT02057900 | COMPLETED | Ischemic Heart Disease |
Assistance Publique - Hôpitaux de Paris |
2013-05-27 | PHASE1 |
| NCT03328117 | COMPLETED | Acute Lung Injury |
Exvastat Ltd. |
2017-11-13 | PHASE1 |
| NCT02465359 | COMPLETED | Chronic Inflammatory Demyelinating Polyneuropathy |
University of South Florida |
2014-09 | |
| NCT03488992 | COMPLETED | Metabolic Syndrome |
USANA Health Sciences |
2017-01-10 | |
| NCT03428997 | COMPLETED | Comedogenicity |
Johnson & Johnson Consumer Inc. (J&JCI) |
2017-11-20 | |
| NCT02879877 | COMPLETED | Healthy Volunteers |
UCB Biopharma S.P.R.L. |
2016-07-11 | PHASE1 |
| NCT02877030 | COMPLETED | HTLV-1 |
Pedreira, Érika, M.D. |
2017-04-02 | |
| NCT03394508 | COMPLETED | Rhinitis; Asthma; Allergy |
Karolinska Institutet |
2013-01 | PHASE2; PHASE3 |
| NCT03643380 | COMPLETED | Overactive Bladder |
Neuspera Medical, Inc. |
2017-08-17 | PHASE1 |
| NCT01941745 | COMPLETED | Respiratory Distress Syndrome in Premature Infant; Bronchopulmonary Dysplasia |
Tufts Medical Center |
2013-10 | PHASE2 |
| NCT01619020 | COMPLETED | Healthy |
Fred Hutchinson Cancer Center |
2012-10 | |
| NCT01814436 | UNKNOWN | Dental Pulp Necrosis; Permanent Incisor Avulsed by Trauma |
Air Force Military Medical University, China |
2013-02 | |
| NCT03198676 | COMPLETED | Upper Respiratory Tract Infections |
Prep Biopharm Limited |
2017-05-08 | PHASE1 |
| NCT03121339 | COMPLETED | Seasonal Influenza Preventative Vaccine Pharmacodynamics |
Vaxart |
2017-03-31 | PHASE1 |
| NCT02877667 | COMPLETED | Tattoo |
Soliton |
2016-07 | |
| NCT02789527 | COMPLETED | Healthy |
Estella S. Poloni |
2015-11 | |
| NCT02390466 | UNKNOWN | HIV |
InnaVirVax |
2015-04 | PHASE1; PHASE2 |
| NCT03294161 | COMPLETED | Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis; American |
Hospital Universitário Professor Edgard Santos |
2014-12 | PHASE2 |
| NCT02527096 | COMPLETED | HIV-1 Infection |
ANRS, Emerging Infectious Diseases |
2015-09-17 | PHASE2 |
| NCT02634528 | COMPLETED | Diabetes Mellitus |
Julphar Gulf Pharmaceutical Industries |
2016-11-16 | PHASE1 |
| NCT02244073 | TERMINATED | Critical Illness |
Hospices Civils de Lyon |
2015-05 | |
| NCT01754454 | UNKNOWN | Acute GVH Disease |
Affiliated Hospital to Academy of Military Medical Sciences |
2012-12 | PHASE1; PHASE2 |
| NCT02922673 | COMPLETED | Endotoxemia |
Radboud University Medical Center |
2016-09 | |
| NCT01751386 | COMPLETED | Alcoholism; Alcohol Dependence; Alcohol Drinking Related Problems; Alcohol Drinking; Anxiety Disorder |
National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
2012-12-03 | PHASE2 |
| NCT03558321 | COMPLETED | Postmenopausal Bleeding |
Cairo University |
2014-06 | |
| NCT02078193 | COMPLETED | Kidney Transplantation |
East Carolina University |
2013-11 | PHASE4 |
| NCT02312492 | COMPLETED | Dyslipidemia |
Tufts University |
2013-01 | |
| NCT02061722 | COMPLETED | Huntington's Disease |
CHDI Foundation, Inc. |
2013-01 | EARLY_PHASE1 |
| NCT02040558 | TERMINATED | Advanced Solid Tumors |
Mallinckrodt |
2013-07 | PHASE1 |
| NCT02321410 | COMPLETED | Carotid Artery Disease; Plaque Neovascularization |
Ospedale San Giovanni Bellinzona |
2014-02 | |
| NCT01783847 | COMPLETED | Traumatic Optic Neuropathy |
Tehran University of Medical Sciences |
2015-02 | PHASE1; PHASE2 |
| NCT02714166 | COMPLETED | Sunscreening Agents |
Bayer |
2016-02-26 | |
| NCT01375556 | TERMINATED | Alcoholism; Genetics |
National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
2011-05-26 | PHASE1 |
| NCT02041975 | COMPLETED | Obesity |
University of Reading |
2013-10 | |
| NCT03330678 | COMPLETED | Probiotics |
Sanjay Gandhi Postgraduate Institute of Medical Sciences |
2013-12 | |
| NCT02439047 | TERMINATED | Cancer |
Centre Oscar Lambret |
2015-06 | |
| NCT01665573 | COMPLETED | Fear Conditioning |
Yale University |
2012-07-17 | EARLY_PHASE1 |
| NCT00957671 | COMPLETED | Growth Hormone Deficiency; Traumatic Brain Injury |
The University of Texas Medical Branch, Galveston |
2003-11 | PHASE4 |
| NCT02740790 | COMPLETED | Human Papillomavirus |
Shanghai Zerun Biotechnology Co.,Ltd |
2013-09 | PHASE2 |
| NCT01950325 | COMPLETED | HIV-1 Infection; Neutralizing Antibody; Monoclonal Antibody; Viral Load; HIV Antibodies |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-08-22 | PHASE1 |
| NCT03956433 | COMPLETED | Metabolic Syndrome |
University of Leeds |
2014-09-01 | |
| NCT02261168 | COMPLETED | Diabetes Mellitus, Type 2; Insulin Resistance |
Maastricht University Medical Center |
2014-11 | |
| NCT02059694 | WITHDRAWN | Upper Eyelid Surgery |
Duke University |
||
| NCT02080026 | COMPLETED | Malaria |
Radboud University Medical Center |
2014-06 | |
| NCT02338089 | COMPLETED | Postpartum Hemorrhage |
Samuel Lunenfeld Research Institute, Mount Sinai Hospital |
2015-01 | |
| NCT01984801 | COMPLETED | Acne Vulgaris |
GlaxoSmithKline |
2013-10-14 | PHASE1 |
| NCT01988792 | COMPLETED | Premature; Infant; Enteral Nutrition; Human Milk; Fortification |
University of Tennessee |
2013-11 | |
| NCT02401113 | COMPLETED | Sarcopenia |
Pusan National University Hospital |
2014-11 | PHASE2; PHASE3 |
| NCT02549053 | COMPLETED | Barrett Esophagus |
University Hospital, Angers |
2012-02 | |
| NCT02320838 | COMPLETED | Pain |
University of Castilla-La Mancha |
2014-11 | |
| NCT01951508 | COMPLETED | Healthy; Substance-related Disorder; Mood Disorder |
University Hospital, Basel, Switzerland |
2013-10 | EARLY_PHASE1 |
| NCT01124981 | COMPLETED | Fibrinogen Deficiency in Complex Cardiac Surgery |
Isala |
2011-02 | PHASE2; PHASE3 |
| NCT02073656 | COMPLETED | Hepatitis C Virus; HIV |
Gilead Sciences |
2014-02 | PHASE3 |
| NCT02205554 | COMPLETED | Pain |
Syntrix Biosystems, Inc. |
2014-08 | PHASE1 |
| NCT01245322 | COMPLETED | Bacterial Vaginosis |
Skaraborg Hospital |
2007-01 | PHASE4 |
| NCT03315325 | COMPLETED | Sterility, Reproductive |
Quaid-e-Azam University |
2014-08-08 | PHASE3 |
| NCT03286517 | COMPLETED | Reproductive Physiological Phenomena |
Ghulam Nabi |
2014-06-26 | PHASE3 |
| NCT01386294 | COMPLETED | HIV Prevention |
CONRAD |
2011-10 | PHASE3 |
| NCT02018263 | COMPLETED | Cocaine Dependence |
Yale University |
2013-10 | PHASE1 |
| NCT01497197 | TERMINATED | Infertility; Fertility; Follicle Stimulating Hormone Deficiency |
Merck KGaA, Darmstadt, Germany |
2012-05 | PHASE3 |
| NCT01747980 | COMPLETED | Gaucher Disease |
Protalix |
2013-03 | PHASE1 |
| NCT01722526 | COMPLETED | Human Acid Sphingomyelinase Deficiency |
Genzyme, a Sanofi Company |
2013-03 | PHASE1 |
| NCT02017132 | UNKNOWN | Obesity; Diabetes; Cardiovascular Disease |
Queen Margaret University |
2013-04 | |
| NCT01218594 | UNKNOWN | Non-small Cell Lung Cancer |
Sun Yat-sen University |
2009-05 | PHASE2 |
| NCT03771326 | COMPLETED | Kisspeptin Action on Insulin in Healthy Normal Men; Kisspeptin Action on Insulin in Obese Diabetic Men |
Quaid-e-Azam University |
2013-10-29 | PHASE3 |
| NCT01685333 | COMPLETED | Healthy |
Azidus Brasil |
2013-02-28 | PHASE1 |
| NCT01483248 | UNKNOWN | Liver Cirrhosis; Fibrosis; Liver Disease; Digestive System Disease |
S-Evans Biosciences Co., Ltd. |
2010-10 | PHASE1; PHASE2 |
| NCT01437163 | COMPLETED | Androgenetic Alopecia |
Apira Science, Inc. |
2011-09 | |
| NCT01879813 | COMPLETED | Cognitive Performance (Focus) |
University of Leeds |
2012-10 | |
| NCT01734057 | WITHDRAWN | Purpura; Idiopathic Thrombocytopenic Purpura |
Shandong University |
2012-07 | PHASE3 |
| NCT01009567 | COMPLETED | Ovarian Hyperstimulation Syndrome |
Royan Institute |
2009-06 | PHASE1; PHASE2 |
| NCT00719212 | COMPLETED | Ovarian Neoplasms |
Translational Research in Oncology |
2009-01 | PHASE2 |
| NCT01305356 | COMPLETED | Degenerative Joint Disease; Congenital Deformity; Arthritis; Osteoarthritis; Rheumatoid Arthritis |
BioMimetic Therapeutics |
2011-03 | |
| NCT02974894 | COMPLETED | Stress Reaction |
Lund University |
2013-02 | |
| NCT00313716 | COMPLETED | Anemia; Traumatic Brain Injury |
Claudia Sue Robertson |
2006-04 | PHASE2; PHASE3 |
| NCT02133495 | COMPLETED | Lower Eyelid Retraction |
SGM Physician Research Consortium |
2011-01 | |
| NCT01007071 | COMPLETED | Hypopituitarism |
Stanford University |
2009-11-01 | PHASE3 |
| NCT01624038 | UNKNOWN | Thalassemia Intermedia |
Ain Shams University |
2012-06 | PHASE2; PHASE3 |
| NCT01312246 | WITHDRAWN | Colon and Rectal Diseases |
University of Illinois at Chicago |
2011-04 | |
| NCT01271829 | COMPLETED | Satiety; Glycemic Index; Insulin; Gastrointestinal Peptides and Hormones |
Loma Linda University |
2011-01 | |
| NCT01341912 | COMPLETED | Severe Hemophilia A |
Octapharma |
2011-06 | PHASE3 |
| NCT02025686 | COMPLETED | Pain; Inflammation; Hyperalgesia |
Per Rotbøll Nielsen |
2012-03 | |
| NCT01735370 | COMPLETED | Fasting |
IPCA Laboratories Ltd. |
2012-05 | PHASE1 |
| NCT01649024 | UNKNOWN | Malignant Mesothelioma |
Azienda Ospedaliera Universitaria Senese |
2009-05 | PHASE2 |
| NCT01490762 | COMPLETED | Healthy |
Mannkind Corporation |
2011-12 | PHASE1 |
| NCT01503216 | COMPLETED | Vitamin D Deficiency |
Ulrike Lehmann |
2012-01 | |
| NCT01438749 | COMPLETED | Healthy Volunteer |
Hoffmann-La Roche |
2011-10 | PHASE1 |
| NCT00722839 | COMPLETED | Nonneoplastic Condition |
City of Hope Medical Center |
2006-12 | PHASE1 |
| NCT01268150 | COMPLETED | Locally Recurrent; Metastatic Breast Cancer ( HER2 Negative) |
Eisai Inc. |
2011-02 | PHASE2 |
| NCT00604175 | COMPLETED | HIV Infections; Sexually Transmitted Diseases |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-02 | PHASE2 |
| NCT01356823 | COMPLETED | Cervical Intraepithelial Neoplasia; Cervical Cancer |
Xiamen University |
2011-03 | PHASE2 |
| NCT01265875 | COMPLETED | Chronic Pancreatitis |
ChiRhoClin, Inc. |
2010-12 | PHASE1; PHASE2 |
| NCT00989196 | COMPLETED | Hemophilia A |
Octapharma |
2010-05 | PHASE2 |
| NCT01416324 | COMPLETED | Diabetes Mellitus, Type 2 |
GlaxoSmithKline |
2011-06-15 | PHASE1 |
| NCT01106729 | COMPLETED | Metabolism and Clearance of Cyanidin 3 Glucoside |
University of East Anglia |
2011-07 | |
| NCT01367886 | COMPLETED | Overactive Bladder |
Washington University School of Medicine |
2010-08 | |
| NCT01056549 | COMPLETED | Hyperlipidemia |
University Health Network, Toronto |
2010-01 | |
| NCT01334151 | COMPLETED | Diabetes Mellitus Type 1 |
Biodel |
2011-03 | PHASE1 |
| NCT01342250 | COMPLETED | Liver Cirrhosis |
Shenzhen Beike Bio-Technology Co., Ltd. |
2010-10 | PHASE1; PHASE2 |
| NCT03209895 | COMPLETED | Joint Pain |
U.S. Nutraceuticals, LLC |
2010-10-08 | |
| NCT04874324 | COMPLETED | Pharmacokinetics |
Wockhardt |
2011-03-17 | PHASE1 |
| NCT01310478 | UNKNOWN | Colorectal Neoplasm |
Fudan University |
2010-08 | PHASE1 |
| NCT00953472 | TERMINATED | Hypertension Stage 1 |
Mayo Clinic |
2009-02 | PHASE1 |
| NCT00250211 | COMPLETED | Glioblastoma; Glioma |
AHS Cancer Control Alberta |
2005-03 | PHASE1; PHASE2 |
| NCT01380366 | COMPLETED | Short Bowel Syndrome |
Northwestern University |
2006-10 | PHASE4 |
| NCT03409510 | COMPLETED | Healthy Volunteers |
Bispebjerg Hospital |
2010-11-01 | |
| NCT01691469 | COMPLETED | Healthy |
Dr. Reddy's Laboratories Limited |
2011-01 | PHASE1 |
| NCT00283400 | TERMINATED | Subarachnoid Hemorrhage |
Baylor College of Medicine |
2006-01 | |
| NCT00181610 | COMPLETED | Lactation |
Massachusetts General Hospital |
2004-09 | PHASE2 |
| NCT01011296 | COMPLETED | Healthy Volunteers |
Pfizer |
2009-12 | PHASE1 |
| NCT00513526 | COMPLETED | Infection; Precancerous Condition |
AIDS Malignancy Consortium |
2007-11 | PHASE2 |
| NCT00570960 | TERMINATED | Spontaneous Bacterial Peritonitis |
University of Virginia |
2007-06 | PHASE4 |
| NCT00916448 | COMPLETED | Endotoxemia; Inflammation; Multi Organ Dysfunction Syndrome; Sepsis |
Radboud University Medical Center |
2009-05 | |
| NCT00600054 | COMPLETED | Recurrent Diffuse Pontine Gliomas |
YM BioSciences |
2007-10 | PHASE2 |
| NCT00292981 | COMPLETED | Hereditary Angioedema |
CSL Behring |
2005-08 | PHASE3 |
| NCT00972582 | COMPLETED | Healthy |
The Hospital for Sick Children |
2009-05 | PHASE1 |
| NCT00548444 | COMPLETED | Tuberculosis |
University of Oxford |
2007-10 | PHASE1 |
| NCT01060722 | COMPLETED | Healthy |
OPKO Health, Inc. |
2009-10 | PHASE1 |
| NCT00646568 | COMPLETED | Infertility |
Hadassah Medical Organization |
2008-06 | |
| NCT00832663 | COMPLETED | Muscle Damage |
Bispebjerg Hospital |
2009-04 | |
| NCT00773175 | COMPLETED | Dehydration |
Halozyme Therapeutics |
2008-10 | PHASE4 |
| NCT00910390 | COMPLETED | Human Embryo Cryopreservation |
Erasme University Hospital |
2009-04 | |
| NCT00858923 | UNKNOWN | HIV; HIV Infections |
Energex Systems, Inc. |
2008-07 | PHASE1 |
| NCT00776165 | COMPLETED | Chemotherapy-Induced Neutropenia |
Shantha Biotechnics Limited |
2007-10 | PHASE3 |
| NCT00356486 | COMPLETED | HIV Infections |
Germans Trias i Pujol Hospital |
2005-10 | PHASE4 |
| NCT00774800 | COMPLETED | Type 1 Diabetes Mellitus |
Halozyme Therapeutics |
2008-10 | PHASE2 |
| NCT00582010 | COMPLETED | Reperfusion Injury; Liver Injury |
University of Alabama at Birmingham |
2008-04 | PHASE2; PHASE3 |
| NCT01513057 | COMPLETED | Healthy |
Dr. Reddy's Laboratories Limited |
2009-01 | PHASE1 |
| NCT00348387 | COMPLETED | Poliomyelitis; Polio |
Sanofi Pasteur, a Sanofi Company |
2006-06 | PHASE3 |
| NCT00613379 | COMPLETED | HIV Infections |
CytoDyn, Inc. |
2007-12 | PHASE2 |
| NCT00668538 | COMPLETED | Healthy |
University of Southern Denmark |
2008-04 | |
| NCT00808704 | COMPLETED | Hypoxic-Ischemic Encephalopathy |
Zhengzhou University |
2003-08 | PHASE1; PHASE2 |
| NCT00003993 | COMPLETED | Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
National Institute on Aging (NIA) |
1999-09 | PHASE1 |
| NCT00246012 | COMPLETED | Melanoma |
Centocor, Inc. |
2005-05 | PHASE1; PHASE2 |
| NCT00437112 | COMPLETED | Diabetes Mellitus, Type 2 |
Eli Lilly and Company |
2007-02 | PHASE3 |
| NCT00585650 | COMPLETED | Psoriasis |
University of California, Irvine |
2007-05 | PHASE1; PHASE2 |
| NCT01996475 | COMPLETED | Healthy |
Torrent Pharmaceuticals Limited |
PHASE1 | |
| NCT00618839 | COMPLETED | Third Degree Burn; Burns; Wound Infection; Degloving Injury |
Stratatech, a Mallinckrodt Company |
2006-07 | PHASE1; PHASE2 |
| NCT00636038 | COMPLETED | Vitamin A Status |
Tufts University |
2008-01 | PHASE1 |
| NCT00718653 | COMPLETED | Eye Health |
National Eye Institute (NEI) |
2004-09 | |
| NCT00260234 | TERMINATED | Diabetes Mellitus, Type 1 |
Novocell |
2005-11 | PHASE1; PHASE2 |
| NCT00954824 | COMPLETED | Metabolic Syndrome X |
University of Pennsylvania |
2003-08 | |
| NCT00479258 | TERMINATED | Diabetes Mellitus, Type 1 |
Pfizer |
2007-10 | PHASE3 |
| NCT00071240 | COMPLETED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
2002-10 | PHASE2 |
| NCT00846950 | COMPLETED | Cognition |
Maastricht University Medical Center |
2006-12 | |
| NCT00325130 | COMPLETED | Neoplasms, Glandular and Epithelial; Diphtheria; Tetanus; Whooping Cough; Meningitis |
Merck Sharp & Dohme LLC |
2006-04 | PHASE3 |
| NCT00274703 | COMPLETED | Oesophagitis, Eosinophilic |
GlaxoSmithKline |
2005-12 | PHASE2 |
| NCT00392457 | COMPLETED | Kallmann Syndrome; Hypogonadism; Gonadal Disorder |
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
1995-07 | |
| NCT01267396 | COMPLETED | Healthy |
Dr. Reddy's Laboratories Limited |
2006-09 | PHASE1 |
| NCT01687556 | COMPLETED | Acne Vulgaris |
Seoul National University Hospital |
2005-07 | |
| NCT00206934 | COMPLETED | Healthy Volunteers |
University of Copenhagen |
2005-03 | |
| NCT00079898 | COMPLETED | Healthy |
National Center for Complementary and Integrative Health (NCCIH) |
2002-07 | |
| NCT02090933 | COMPLETED | No Evidence of Disease |
National Cancer Institute (NCI) |
2004-03 | PHASE2 |
| NCT01494493 | TERMINATED | Degenerative Disc Disease |
Medtronic Spinal and Biologics |
2000-09 | |
| NCT00853190 | COMPLETED | Healthy |
Mallinckrodt |
2003-09 | PHASE1 |
| NCT00778583 | COMPLETED | Healthy |
Ranbaxy Laboratories Limited |
2003-09 | |
| NCT01448070 | COMPLETED | Diabetes; Healthy |
Novo Nordisk A/S |
2002-10-15 | PHASE1 |
| NCT00775827 | COMPLETED | Healthy |
Ranbaxy Laboratories Limited |
2002-11 | |
| NCT00001309 | COMPLETED | Healthy Volunteers |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
1997-01-23 | PHASE1 |
| NCT00137891 | COMPLETED | Healthy |
Genzyme, a Sanofi Company |
2005-06 | PHASE1 |
| NCT00297960 | COMPLETED | Healthy Male Volunteers |
Medical University of Vienna |
2005-04 | PHASE4 |
| NCT00021580 | UNKNOWN | Diabetes Mellitus |
National Center for Research Resources (NCRR) |
PHASE1 | |
| NCT00000683 | COMPLETED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE1 | |
| NCT00000845 | COMPLETED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE1 | |
| NCT01418586 | COMPLETED | Healthy |
Torrent Pharmaceuticals Limited |
PHASE1 | |
| NCT00004401 | COMPLETED | Infant Botulism; Botulism |
California Department of Health Services |
1998-01 | |
| NCT00140374 | COMPLETED | Prostate Cancer |
Cell Genesys |
1998-12 | PHASE1; PHASE2 |
| NCT00155935 | UNKNOWN | Ovarian Cancer |
National Taiwan University Hospital |
2004-01 | |
| NCT00507364 | UNKNOWN | Biological Therapy for Chronic Anal Fissure; Treatment by Biological Factors - Activated Macrophages; Interventional Study |
Hadassah Medical Organization |
PHASE3 | |
| NCT00000684 | COMPLETED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
||
| NCT01218711 | COMPLETED | Healthy |
Torrent Pharmaceuticals Limited |
PHASE1 |
(data from https://clinicaltrials.gov, updated on 2026-01-06)
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Kisspeptin-10 (human) Solubility in DMSO
- Kisspeptin-10 (human) Stock Solution
- Kisspeptin-10 (human) Storage
- Kisspeptin-10 (human) Stability
- Kisspeptin-10 (human) Molecular Weight
- Kisspeptin-10 (human) SMILES
- Kisspeptin-10 (human) CAS Number
- Kisspeptin-10 (human) Chemical Structure (2D and 3D)
- Kisspeptin-10 (human) SDS|MSDS